Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
YL Ventures is a prominent venture capital firm that specializes in seed-stage investments in Israeli cybersecurity startups. Founded in 2007 by Yoav Leitersdorf, the firm operates out of Silicon Valley and Tel Aviv, managing approximately $800 million in assets across several funds. YL Ventures is distinguished by its high-conviction, "value-add" investment strategy, providing portfolio companies with extensive strategic guidance and access to a global network of over 100 Chief Information Security Officers (CISOs). While its primary focus is cybersecurity, the firm's portfolio includes companies that impact the healthcare sector, such as Medigate, which provides security and asset management for medical IoT devices. The firm has a strong track record of backing startups that have achieved significant exits to major corporations like Microsoft, Palo Alto Networks, and Proofpoint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on YL Ventures.